Vulnerability · Published Dec 4, 2025 · Assigned by VulnCheck
CVE-2023-53734dawa-pharma-1.0 - SQL Injection via Email Parameter
High 8.7
In plain English
A high-severity SQL injection in dawa-pharma from mayurik. Proof-of-concept exploit code is public. The chance it is exploited in the next 30 days is estimated at 0.6% (higher than 47% of all known vulnerabilities).
Severity (CVSS 4.0)8.7High
Exploit odds (30 days)0.6%top 52.8% of all CVEs
Exploited in the wildNo reportsCISA SSVC: poc
Attack toolingNoneno public tooling known
Official description
dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| mayurik | dawa-pharma | 1.0-2022 |
Weakness: CWE-89 · Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
References
- ExploitDB-51818 exploit
- Mayuri K Pharmacy Billing Software product
- GitHub Repository for CVE-nu11secur1ty product, issue-tracking
- nu11secur1ty Home Page product
- https://www.vulncheck.com/advisories/dawa-pharma-10-sql-injection-via-email-parameter third-party-advisory